Literature DB >> 16547242

EphA receptors inhibit anti-CD3-induced apoptosis in thymocytes.

Andrew Freywald1, Nigel Sharfe, Charlotte D'E Miller, Cher Rashotte, Chaim M Roifman.   

Abstract

The EphA receptor tyrosine kinases interact with membrane-bound ligands of the ephrin-A subfamily. Interaction induces EphA receptor oligomerization, tyrosine phosphorylation, and, as a result, EphA receptor signaling. EphA receptors have been shown to regulate cell survival, migration, and cell-cell and cell-matrix interactions. However, their functions in lymphoid cells are only beginning to be described. We show in this study that functional EphA receptors are expressed by murine thymocytes, including CD4(+)CD8(+), CD4(+)CD8(-), and CD4(-)CD8(+) subpopulations. We demonstrate that activation of EphA receptors by the ephrin-A1 ligand inhibits the anti-CD3-induced apoptosis of CD4(+)CD8(+) double-positive thymocytes. Furthermore, ephrin-A1 costimulation suppresses up-regulation of both the IL-2R alpha-chain (CD25) and early activation Ag CD69 and can block IL-2 production by CD4(+) single-positive cells. In agreement, EphA receptor activation in thymocytes also inhibits TCR-induced activation of the Ras-MAPK pathway. Our findings suggest that EphA receptor activation is antithetical to TCR signaling in thymocytes, and that the level of engagement by ephrin-A proteins on thymic APCs regulates thymocyte selection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16547242     DOI: 10.4049/jimmunol.176.7.4066

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Alterations in the thymocyte phenotype of EphB-deficient mice largely affect the double negative cell compartment.

Authors:  David Alfaro; Juan José Muñoz; Javier García-Ceca; Teresa Cejalvo; Eva Jiménez; Agustín Zapata
Journal:  Immunology       Date:  2008-04-04       Impact factor: 7.397

Review 2.  Regulation of cell differentiation by Eph receptor and ephrin signaling.

Authors:  David G Wilkinson
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

3.  Accelerated thymocyte maturation in IL-12Rβ2-deficient mice contributes to increased susceptibility to autoimmune inflammatory demyelination.

Authors:  B Gran; S Yu; G X Zhang; A Rostami
Journal:  Exp Mol Pathol       Date:  2010-06-30       Impact factor: 3.362

4.  Efnb1 and Efnb2 proteins regulate thymocyte development, peripheral T cell differentiation, and antiviral immune responses and are essential for interleukin-6 (IL-6) signaling.

Authors:  Hongyu Luo; Tania Charpentier; Xuehai Wang; Shijie Qi; Bing Han; Tao Wu; Rafik Terra; Alain Lamarre; Jiangping Wu
Journal:  J Biol Chem       Date:  2011-10-05       Impact factor: 5.157

5.  Eph/Ephrin-mediated stimulation of human bone marrow mesenchymal stromal cells correlates with changes in cell adherence and increased cell death.

Authors:  David Alfaro; Agustín G Zapata
Journal:  Stem Cell Res Ther       Date:  2018-06-26       Impact factor: 6.832

Review 6.  Emerging Roles for Eph Receptors and Ephrin Ligands in Immunity.

Authors:  Thayer K Darling; Tracey J Lamb
Journal:  Front Immunol       Date:  2019-07-04       Impact factor: 7.561

7.  DNA-coated AFM cantilevers for the investigation of cell adhesion and the patterning of live cells.

Authors:  Sonny C Hsiao; Ailey K Crow; Wilbur A Lam; Carolyn R Bertozzi; Daniel A Fletcher; Matthew B Francis
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

Review 8.  Eph receptors and ephrin signaling pathways: a role in bone homeostasis.

Authors:  Claire M Edwards; Gregory R Mundy
Journal:  Int J Med Sci       Date:  2008-09-03       Impact factor: 3.738

9.  The expression of netrin-1 in the thymus and its effects on thymocyte adhesion and migration.

Authors:  Xiao-Kai Guo; Yuan-Feng Liu; Yu Zhou; Xiu-Yuan Sun; Xiao-Ping Qian; Yu Zhang; Jun Zhang
Journal:  Clin Dev Immunol       Date:  2013-11-28

Review 10.  Eph/ephrin Signaling and Biology of Mesenchymal Stromal/Stem Cells.

Authors:  David Alfaro; Mariano R Rodríguez-Sosa; Agustín G Zapata
Journal:  J Clin Med       Date:  2020-01-22       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.